Your browser doesn't support javascript.
loading
p53 expression in cytology samples may represent a marker of early-stage cancer.
Policardo, Federica; Tralongo, Pietro; Arciuolo, Damiano; Fiorentino, Vincenzo; Cardasciani, Lina; Pierconti, Francesco; Carlino, Angela; Curatolo, Mariangela; Pontecorvi, Alfredo; Fadda, Guido; De Crea, Carmela; Lombardi, Celestino Pio; Raffaelli, Marco; Larocca, Luigi Maria; Pantanowitz, Liron; Rossi, Esther Diana.
Afiliación
  • Policardo F; Division of Anatomic Pathology and Histology, Catholic University of Sacred Hearth, Rome, Italy.
  • Tralongo P; Division of Anatomic Pathology and Histology, Catholic University of Sacred Hearth, Rome, Italy.
  • Arciuolo D; Division of Anatomic Pathology and Histology, Catholic University of Sacred Hearth, Rome, Italy.
  • Fiorentino V; Division of Anatomic Pathology and Histology, Catholic University of Sacred Hearth, Rome, Italy.
  • Cardasciani L; Division of Anatomic Pathology and Histology, Catholic University of Sacred Hearth, Rome, Italy.
  • Pierconti F; Division of Anatomic Pathology and Histology, Catholic University of Sacred Hearth, Rome, Italy.
  • Carlino A; Division of Anatomic Pathology and Histology, Catholic University of Sacred Hearth, Rome, Italy.
  • Curatolo M; Division of Anatomic Pathology and Histology, Catholic University of Sacred Hearth, Rome, Italy.
  • Pontecorvi A; Division of Endocrinology, Catholic University, Rome, Italy.
  • Fadda G; Division of Anatomic Pathology and Histology, Catholic University of Sacred Hearth, Rome, Italy.
  • De Crea C; Division of Endocrine-Surgery, Fondazione Policlinico Universitario "Agostino Gemelli"-IRCCS, Rome, Italy.
  • Lombardi CP; Division of Endocrine-Surgery, Fondazione Policlinico Universitario "Agostino Gemelli"-IRCCS, Rome, Italy.
  • Raffaelli M; Division of Endocrine-Surgery, Fondazione Policlinico Universitario "Agostino Gemelli"-IRCCS, Rome, Italy.
  • Larocca LM; Division of Anatomic Pathology and Histology, Catholic University of Sacred Hearth, Rome, Italy.
  • Pantanowitz L; Department of Pathology, University of Michigan, Ann Arbor, Michigan, USA.
  • Rossi ED; Division of Anatomic Pathology and Histology, Catholic University of Sacred Hearth, Rome, Italy.
Cancer Cytopathol ; 131(6): 392-401, 2023 06.
Article en En | MEDLINE | ID: mdl-36974003
BACKGROUND: TP53 gene plays a major role in the negative control of cell proliferation and in the regulation of signaling cascades. TP53 mutation may have a relevant role in the malignant transformation of thyroid cells as well as thyroid tumor progression. TP53 mutation has been detected only in few well differentiated thyroid carcinomas and is absent in benign conditions. METHODS: A total of 162 prospective thyroid cytology and corresponding histological samples diagnosed from atypia of indeterminate significance (AUS) to malignant, were studied via immunocytochemistry for p53. Hence, 50 benign lesions (B) were used as negative control. Molecular analysis for p53 only was performed. RESULTS: The cytology resulted in 50 B, 48 AUS, 40 follicular neoplasms (FNs), 23 suspicious for malignancy (SFM), and 1 malignant (M) case. The authors reported 102 negative and 60 positive p53 cases. The 60 positive cases included 27 cases with weak and/or focal cytoplasmic positivity (+1) and 33 with cases moderate (2+) to strong (3+) cytoplasmic and/or nuclear expression. Overall, 71 cases had histology (2 B, 11 AUS, 37 FN, 20 SFM, and 1 M) including 61.7% benign and 38.2% malignant diagnoses. Only 16 of 71 (5 FN, 10 SFM, and 1 M) were p53-positive. Furthermore, 100% AUS and 86.5% FN cases were p53-negative, none of which had malignant histology. All p53-positive cases were associated with a larger nodule size, tall-cell variant subtype, multifocality, extra thyroidal infiltration, and nodal metastases. Noninvasive follicular thyroid neoplasm with papillary like nuclear features were negative for p53. Few discrepancies in p53 intensity were observed on histology; there were no differences with the molecular testing. CONCLUSIONS: p53 might be useful in discriminating thyroid follicular lesions. p53 is likely to be a useful diagnostic marker in recognizing indeterminate lesions that are well-differentiated thyroid cancers.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de la Tiroides / Nódulo Tiroideo / Adenocarcinoma Folicular Tipo de estudio: Diagnostic_studies / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Cancer Cytopathol Año: 2023 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de la Tiroides / Nódulo Tiroideo / Adenocarcinoma Folicular Tipo de estudio: Diagnostic_studies / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Cancer Cytopathol Año: 2023 Tipo del documento: Article País de afiliación: Italia